THE STANDARD OF CARE IN RELAPSED REFRACTORY CD30+ LYMPHOMA
CD30-positive (CD30+) lymphomas are a heterogeneous group of hematological malignancies that share the same antigen. Over recent decades, advances in therapeutic management of these diseases have considerably improved clinical outcomes. Overall, the two main CD30+ lymphomas – Hodgkin’s lymphoma and...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2014-07-01
|
| Series: | European Medical Journal Hematology |
| Subjects: | |
| Online Access: | https://emj.emg-health.com/wp-content/uploads/sites/2/2018/02/The-Standard-of-Care-in-Relapsed-Refractory-CD30-Lymphoma.pdf |